liquid biopsy

Harbinger Health foreshadows launch of blood-based cancer screening platform with $140M VC round
Harbinger Health foreshadows launch of blood-based cancer screening platform with $140M VC round
Fierce Biotech
Harbinger Health
Medtech
diagnostics
cancer
funding
liquid biopsy
Flag link:
Experts spar over the benefits of liquid biopsy to catch cancer
Experts spar over the benefits of liquid biopsy to catch cancer
Stat
cancer
diagnostics
liquid biopsy
Flag link:
Quest Expands in Cancer Testing With $300M Haystack Oncology Acquisition
Quest Expands in Cancer Testing With $300M Haystack Oncology Acquisition
MedCity News
Quest Diagnostics
Haystack Oncology
diagnostics
M&A
liquid biopsy
Medtech
Flag link:
Baltimore Liquid Biopsy Startup Haystack Oncology Raises $56M in Series A Round
Baltimore Liquid Biopsy Startup Haystack Oncology Raises $56M in Series A Round
Bizjournals
funding
Haystack Oncology
diagnostics
liquid biopsy
cancer
oncology
Flag link:
Delfi aims for a cheaper liquid biopsy
Delfi aims for a cheaper liquid biopsy
EP Vantage
Delfi Diagnostics
liquid biopsy
diagnostics
Medtech
cancer
solid tumors
Flag link:
Would Illumina’s acquisition of GRAIL constrict the expansion of the liquid biopsy space?
Would Illumina’s acquisition of GRAIL constrict the expansion of the liquid biopsy space?
MedCity News
Illumina
Grail
M&A
liquid biopsy
Flag link:
Guardant steps into a new arena
Guardant steps into a new arena
EP Vantage
Guardant Health
liquid biopsy
immunotherapy
diagnostics
Flag link:
ASCO 2021 – Guardant shoots for the moon
ASCO 2021 – Guardant shoots for the moon
EP Vantage
ASCO 2021
Guardant Health
liquid biopsy
colorectal cancer
Flag link:
Invitae borrows against the future
Invitae borrows against the future
EP Vantage
Invitae
cancer
liquid biopsy
M&A
Flag link:
Illumina Stock Tumbles As FTC Moves To Block $7.1 Billion Grail Acquisition
Illumina Stock Tumbles As FTC Moves To Block $7.1 Billion Grail Acquisition
Investors Business Daily
Illumina
FTC
Grail
M&A
liquid biopsy
Flag link:
10 Big Developments in Medtech’s Fight Against COVID-19
10 Big Developments in Medtech’s Fight Against COVID-19
Medical Devices and Diagnostics Industry
devices
Medtech
pandemic
COVID-19
liquid biopsy
telemedicine
Medtronic
ventilators
diagnostics
digital health
FDA
Flag link:
A month after Illumina's big Grail buyout, Exact Sciences scoops up liquid biopsy rival Thrive for a relative bargain
A month after Illumina's big Grail buyout, Exact Sciences scoops up liquid biopsy rival Thrive for a relative bargain
Endpoints
EXACT Sciences
M&A
Thrive Earlier Detection
liquid biopsy
diagnostics
Flag link:
Exact gatecrashes the liquid biopsy party
Exact gatecrashes the liquid biopsy party
EP Vantage
EXACT Sciences
liquid biopsy
diagnostics
pan-cancer assay
Flag link:
Foundation Medicine wins FDA OK for pan-tumor test as liquid biopsy market heats up
Foundation Medicine wins FDA OK for pan-tumor test as liquid biopsy market heats up
BioPharma Dive
Foundation Medicine
FDA
cancer
liquid biopsy
diagnostics
solid tumors
pan-cancer
Flag link:
Guardant scores FDA approval for liquid biopsy test
Guardant scores FDA approval for liquid biopsy test
MedCity News
Guardant Health
liquid biopsy
solid tumors
FDA
Flag link:
Genfit trumpets new NASH blood biopsy data
Genfit trumpets new NASH blood biopsy data
Pharmaforum
Genfit
NASH
diagnostics
liquid biopsy
Flag link:
Biocept Files for $27 Million Offering
Biocept Files for $27 Million Offering
CP Wire
Biocept
liquid biopsy
diagnostics
oncology
Flag link:
Here's Why Liquid Biopsy Stocks Fell as Much as 39.2% in September
Here's Why Liquid Biopsy Stocks Fell as Much as 39.2% in September
Motley Fool
liquid biopsy
Adaptive Biotechnologies
Guardant Health
Personalis
Flag link:
Thrive’s quest to bring multicancer liquid biopsy test into routine clinical use
Thrive’s quest to bring multicancer liquid biopsy test into routine clinical use
BioCentury
Thrive Earlier Detection
CancerSEEK
diagnostics
liquid biopsy
Flag link:
Deep Learning Algorithms Are Expected To Boost Liquid Biopsy Techniques
Deep Learning Algorithms Are Expected To Boost Liquid Biopsy Techniques
Forbes
liquid biopsy
diagnostics
deep learning
Flag link:

Pages